Monica Argenziano
Via Pietro Giuria 9
Turin, 10125, Italy
Turin, 10125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Corrigendum to "Exploring new buccal films based on hydroxyethyl cellulose and Linecaps® combination for the pediatric delivery of hydrophobic molecules" [Carbohydrate Polymers 371 (2026) 124499].
Journal: Carbohydrate polymers
Published: July 23, 2026
Albumin Nanoparticles Improve Colistin Performance Against Hetero- and Full-Resistant Clinical A. baumannii: A Mechanistic Study.
Journal: Antibiotics (Basel, Switzerland)
Published: March 18, 2026
Erratum to "Gemcitabine-loaded ICOS-Fc decorated nanosponges: a new chemo immunotherapy combination against pancreatic cancer". [Int. J. Pharm. 682 (2025) 125869].
Journal: International journal of pharmaceutics
Published: January 15, 2026
pH-Sensitive Dextrin-Based Nanosponges Crosslinked with Pyromellitic Dianhydride and Citric Acid: Swelling, Rheological Behavior, Mucoadhesion, and In Vitro Drug Release.
Journal: Gels (Basel, Switzerland)
Published: November 01, 2025
Exploring Anti-Neoplastic Activity of Chitosan Nanobubbles Decorated with ICOS-Fc and Loaded with Paclitaxel in a Human and Murine Model of Melanoma.
Journal: Pharmaceutics
Published: October 14, 2025
Exploring new buccal films based on hydroxyethyl cellulose and Linecaps® combination for the pediatric delivery of hydrophobic molecules.
Journal: Carbohydrate polymers
Published: April 30, 2025
Cyclodextrin-based therapeutics delivery systems: A review of current clinical trials.
Journal: Current research in pharmacology and drug discovery
Published: April 24, 2025
Gemcitabine-loaded ICOS-Fc decorated nanosponges: A new chemo immunotherapy combination against pancreatic cancer.
Journal: International journal of pharmaceutics
Published: February 20, 2025
What are the future applications of chitosan nanobubbles in drug delivery?
Journal: Expert opinion on drug delivery
Published: February 04, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma.
Journal: Nanomedicine (London, England)
Published: January 15, 2025
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells.
Journal: Nanomedicine (London, England)
Published: December 02, 2024
Green solid lipid nanoparticles by coacervation of fatty acids: An innovative cosmetic ingredient for the delivery of anti-age compounds through the skin.
Journal: International journal of pharmaceutics
Published: November 21, 2024
Last Updated: 09/26/2026